This inventor holds 1 USPTO granted patent. Top assignees: Griffth University, La Trobe University. Active years: 2017.
Company Filing History:
1 out of 1 
1 out of 21 
Years Active: 2017
Title: Innovations in Malaria Vaccination by Terry W Spithill
Introduction
Terry W Spithill is a notable inventor based in Bundoora, Australia. She has made significant contributions to the field of immunology, particularly in the development of vaccines for malaria. Her innovative work has the potential to impact global health positively.
Latest Patents
Terry W Spithill holds a patent for a blood-stage malaria vaccine. The patent describes an immunogenic composition designed for use as a blood-stage malaria vaccine, along with methods for producing this composition and treating malaria. The immunogenic composition includes isolated or purified merozoites or red blood cells infected with merozoites, treated with centanamycin or tafuramycin A. Notably, this composition does not include an adjuvant. A single dose of this immunogenic composition is sufficient to protect an animal against subsequent malaria infections by the same isolate, strain, or species used in the composition, or by one or more heterologous isolates, strains, or species.
Career Highlights
Throughout her career, Terry has worked with prestigious institutions, including Griffith University and La Trobe University. Her research has focused on developing effective strategies to combat malaria, showcasing her dedication to improving public health.
Collaborations
Terry has collaborated with esteemed colleagues, including Michael Francis Good and Moses Lee. These partnerships have furthered her research and contributed to advancements in malaria vaccination.
Conclusion
Terry W Spithill's innovative work in malaria vaccination exemplifies her commitment to addressing critical health challenges. Her contributions through patents and collaborations highlight the importance of research in the fight against infectious diseases.